γ Globin chain synthesis
Animal . | Compound . | γ Globin synthesis, . | γ Globin synthesis, . |
---|---|---|---|
. | . | % Baseline . | % Treatment . |
3698 | DMB | 3.1 | 6.4 |
1997 | DMB | 7.0 | 19.6 |
2063 | DMB | 0 | 4.0 |
196 | AMHCA | 0 | 14.6 |
1573 | AMHCA | 3.7 | 13.7 |
2063 | AMHCA | 0 | 2.0 |
Animal . | Compound . | γ Globin synthesis, . | γ Globin synthesis, . |
---|---|---|---|
. | . | % Baseline . | % Treatment . |
3698 | DMB | 3.1 | 6.4 |
1997 | DMB | 7.0 | 19.6 |
2063 | DMB | 0 | 4.0 |
196 | AMHCA | 0 | 14.6 |
1573 | AMHCA | 3.7 | 13.7 |
2063 | AMHCA | 0 | 2.0 |
γ Globin chain synthesis in baboons before and during treatment with AMHCA or DMB. Treatment with the compounds produced an increase in γ globin chain synthesis over baseline; the ratio of γ/γ+β globin × 100 is shown. Doses administered were 200 mg/kg/day for 4 to 6 days, except for animal 2063, which received 150 mg/kg per dose.